Experienced Investigators Delivering Reliable Clinical Trial Outcomes

Agile Clinical Research Trials (ACRT) is supported by a team of highly qualified Principal Investigators and Sub-Investigators with extensive experience across multiple therapeutic areas.

Our investigators are committed to conducting clinical trials with the highest standards of scientific rigor, subject safety, and regulatory compliance, ensuring dependable outcomes for sponsors and CRO partners.

Our investigators bring deep clinical experience and strong research backgrounds, enabling effective protocol implementation, accurate clinical assessments, and consistent oversight throughout the study lifecycle.

ACRT investigators are dedicated to maintaining ICH-GCP compliance, protocol adherence, and high-quality data integrity, contributing to efficient study execution and reliable clinical evidence generation.

Key Investigator Strengths

  • Extensive experience across multiple therapeutic areas
  • Strong understanding of complex clinical trial protocols
  • Commitment to subject safety and ethical research practices
  • Consistent oversight of study conduct and compliance
  • Accurate clinical assessment and endpoint evaluation
  • Active collaboration with sponsors and CRO partners
  • Timely review and approval of study documentation
  • Experience supporting Phase II–IV clinical trials
  • High standards of protocol adherence and data quality
  • Commitment to continuous training and regulatory compliance

Therapeutic Expertise of Investigators

Our investigators have experience supporting clinical trials in:

  • Internal Medicine
  • Cardiology
  • Gastroenterology
  • Rheumatology
  • Central Nervous System (CNS)
  • Women’s Health (OB-GYN)
  • Infectious Diseases
  • Vaccines
  • Rare Diseases
  • Diagnostics
  • Cell & Gene Therapy
  • Digital Health and Mobile App studies

Collaborative Investigator Approach

ACRT investigators work closely with clinical coordinators, data teams, and recruitment specialists to ensure:

  • Efficient study start-up and feasibility review
  • Consistent subject enrollment performance
  • Careful subject monitoring and follow-up
  • Accurate and timely data capture
  • Proper documentation of protocol-required procedures
  • Proactive identification of study risks and mitigation strategies

This collaborative approach helps sponsors maintain confidence in study progress, compliance, and data reliability.

Commitment to Quality and Compliance

Our investigators follow established processes aligned with:

  • ICH-GCP guidelines
  • FDA regulatory requirements
  • HIPAA compliance standards
  • ALCOA data integrity principles

Their experience and oversight contribute to reduced protocol deviations, improved data quality, and readiness for audits and inspections.